Please try another search
BridgeBio Pharma, Inc. (NASDAQ:BBIO) is a biopharmaceutical company focused on developing and commercializing innovative therapies for patients with genetic diseases and cancers. The company has...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) is positioning itself as a leader in the rare disease treatment market, with a focus on innovative biopharmaceuticals driven by genetic causes. The company's...
Ascendis Pharma A/S (NASDAQ:ASND), a biopharmaceutical company focused on developing innovative therapies, stands at a critical juncture as it awaits crucial clinical data and regulatory decisions....
BioMarin Pharmaceutical Inc (NASDAQ:CRSP) , sporting a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks hereCRISPR Therapeutics’ loss per share...
BioMarin Pharmaceutical Inc. (NASDAQ:EBS) , which has a Zacks Rank #1 (Strong Buy). You can see the complete list of today’s Zacks #1 Rank stocks here.Is BMRN going up? Or down? Predict to see...
Sarepta Therapeutics On Monday April 25, 2016 Sarepta Therapeutics (NASDAQ:SRPT) had a FDA advisory panel shoot down its drug Eteplirsen, used to treat patients with Duchenne Muscular Dystrophy --...
Instrument Type
Region
Sector
Industry
Date
Category
Provider